Effect of vitamin D3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19
Author:
Sales Lucas P.ORCID,
Souza Lucas V.B.,
Fernandes Alan L.ORCID,
Murai Igor H.ORCID,
Santos Mayara D.ORCID,
Vendramini Margarete B.G.ORCID,
Oliveira Ricardo M.,
Figueiredo Camille P.ORCID,
Caparbo Valéria F.ORCID,
Gualano BrunoORCID,
Pereira Rosa M.R.ORCID
Reference48 articles.
1. COVID-19 infection and rheumatoid arthritis: faraway, so close!;Favalli;Autoimmun Rev,2020
2. Arthralgia as an initial presentation of COVID-19: observation;Joob;Rheumatol Int,2020
3. Acute pulmonary embolism and COVID-19 pneumonia: a random association?;Danzi;Eur Heart J,2020
4. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome;Zhang;Circulation,2020
5. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China;Qin;Clin Infect Dis,2020